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Abstract: 
Background: Prostate cancer is the most common cancer in American men and is now the second leading cause 
of cancer death in men, exceeded only by lung cancer. It is estimated that in 2003, approximately 220,900 new 
cases and 28,900 prostate cancer related deaths will occur in the United States. The natural history of prostate 
cancer in not very well understood, although three main risk factors have been identified; age, African 
American race and family history. 
Survival in men with prostate cancer is related to many factors, one of the most important being 
extension of the tumor beyond the prostate capsule at the time of diagnosis. Therefore, a screening program for 
prostate cancer should ideally identi.ty those men with more aggressive tumors that have not spread beyond the 
prostate capsule. One ofthe most controversial topics of discussion in prostate cancer has been regarding the 
efficacy of screening. The goal of screening is to detect disease early enough that intervention can be applied so 
as to reduce mortality, however this has not been proven in regards to the modalities used for prostate cancer 
screening. 
Despite the variations in recommendations for screening, some clinicians and researchers believe there 
is benefit to screening at risk men, particularly African Americans and those with a family history of prostate 
cancer. However, many men in these high-risk categories, for a variety of reasons, do not participate in prostate 
cancer screening. Men who have been identified as least likely to participate in prostate cancer screenings are 
African American, 50-59 years of age, and those with low SES. Predictors of participation in health promoting 
behaviors such as cancer screening that have been documented in the literature include demographlcs and 
perceived benefits. Demographlcs include age, race and socioeconomic status. Perceived benefits are described 
as beliefs about the effectiveness of the recommended action in reducing the health threat. The purpose of this 
work is to identifY fuctors associated with sustained participation in free prostate cancer screening programs 
among hlgh risk men. 
Methods: Thls is a case-control study of participants in a free prostate cancer screening program database. The 
men volunteered for screening at the annual free screening program at least one year during the study period 
from 1998-2001. Demographlc data was collected from all screening participants and entered into a database. 
The participants were also asked to include the most important reason they chose to participate in a free prostate 
cancer screening program. Analysis of the demographic data includes identification of predictors of men who 
are non-sustainers, and how they compare to sustainers. Non-sustainers are idenitified as men who participated 
in screening one year, but did not participate in subsequent years. 
Results: There were I 024 participants in the free prostate cancer screening program. Thirty-six percent were 
identified as sustainers. Whites were more li.ke than African Americans to be sustainers, however this was not 
significant. Those with some college education or more were more li.kely to participate in the free screening 
program however when compared to those with higher levels of education, all other groups were more li.kely to 
be sustainers; though only high school graduates were significantly different. Employment status, having a 
regular physician or havi.ng a close acquaintance with prostate cancer does not significantly influence sustained 
participation in the free screening prognnn. The most important reasons reported for participation the screening 
program were convenience and cost. 
Conclusions: Demographic cannot be used as predictors for participation in a free prostate cancer screening 
prognnn. 
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Introduction: 
Prostate cancer is the most common cancer in American men and is now the second 
leading cause of cancer death in men, exceeded only by lung cancer.1 It is estimated that in 
2003, approximately 220,900 new cases and 28,900 prostate cancer related deaths will occur 
in the United States. Prostate cancer comprises approximately 30% of all cancer cases 
diagnosed among Native Americans and Asian Americans, 37% for Caucasians and 
Hispanics, and half of all cancers in African Americans? A man's lifetime risk of 
developing prostate cancer is 1 in 6. 
The natural history and pathophysiology of prostate cancer is not very well 
understood, although three main risk factors have been identified; age, race and family 
history.3 Prostate cancer is rare in men under age 50, but the incidence increases 
exponentially each decade thereafter. One's risk of developing prostate cancer increases 
with age such that men 39 years old or younger have less than a 1 in 10,000 chance, men 40-
59 years old have a 1 in 55 chance and men 60-79 have a 1 in 7 chance in developing 
prostate cancer. In this older age category African American men have a 60% higher 
incidence of prostate cancer than Caucasian men.1,2·4.s The age-adjusted incidence is higher 
in African American males (243.2 per I 00,000) compared with white males (144.6 per 
100,000).2 African American males have a higher mortality from prostate cancer even after 
d .. "' "' 56 a JUSting >Or access to care .actors. , 
Men with a family history of prostate cancer are at increased risk compared to men 
without a family history of the disease.1 Non-hereditary familial clustering is estimated to 
account for 15-20% of prostate cancer cases. First-degree relatives of men with prostate 
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cancer have a threefold increased chance of developing it by age 70 compared to the average 
individua1.2 
Survival in men with prostate cancer is related to many factors, one of the most 
important being extension of the tumor beyond the prostate capsule at the time of diagnosis. 
The ten-year survival among men with cancer confined to the prostate is 75%, compared 
with 55 and 15% respectively, among those with regional extension and distant metastases. 4 
Therefore, a screening program for prostate cancer should ideally identify those men with 
more aggressive tumors that have not spread beyond the prostate capsule. One of the most 
controversial topics of discussion in prostate cancer has been regarding the efficacy of 
'i---
screemng. The goal of screening is to detect disease early enough that intervention can be 
applied so as to reduce disease-related mortality, 7 however this has not yet been proven in 
regards to the modalities used for prostate cancer screening. Digital rectal exam (DRE) and 
measurement of serum prostate specific antigen (PSA) are the most widely used screening 
tests for prostate cancer.4 A current review of the literature gives a very mixed picture in 
regards to the efficacy of prostate cancer screening, with some studies showing a beneficial 
impact of screening, where others do not4 •8•9•10.li,IZ.J3 
Although mortality rates for prostate cancer in the United States have declined by 
4.5% since the introduction ofPSA testing in 1994,4 it is possible that screening programs 
are not solely responsible for this improvement. It is not certain whether lead time and 
length time biases may also account for some of these changes in survival. Alternative 
explanations such as improved treatment also cannot be ruled out. Other significant 
arguments against screening are centered on the issue of overdiagnosis; specifically the 
overdiagnosis of clinically insignificant prostate cancers, as prostate cancer is usually an 
indolent disease and older men are more likely to die from some other cause. 4 Similarly, a 
positive screening test may lead to large numbers of men having significant side effects, such 
as impotence or urinary incontinence, from therapy for prostate cancer with little or no 
benefit in cancer morbidity and mortality. 
Given this ambiguous evidence and the significant burden of disease, current 
recommendations for DRE and PSA screening vary. The American Cancer Society 
recommends that both PSA testing and DRE be offered annually, beginning at age 50, to men 
who have at least a 10-year life expectancy. Men at high risk, such as African Americans, 
should begin testing at age 45. Men at even higher risk, due to multiple first-degree relatives 
affected at an early age, could begin testing at age 40.14 The American Urological 
Association recommends annual screening with PSA and digital rectal exam beginning at age 
40 for African American men and those with a family history of the disease and age 50 for all 
other men,15 whereas the US Preventive Services Task Force earlier this year changed their 
recommendations against screening to a rating of"I"- meaning there is insufficient to 
recommend for or against screening.16 
Despite the variation in recommendations for screening, several researchers 
and clinicians believe there is benefit to screening at risk men, particularly African 
Americans and those with a family history of prostate cancer. However, many men 
in these high-risk categories, for a variety of reasons, do not participate in prostate 
cancer screening. Men who have been identified as least likely to participate in 
prostate cancer screenings are African American, 50-59 years of age, and 
socioeconomically disadvantaged.17 Attempts to explain this phenomenon have 
drawn upon the Health Belief Model for use as a conceptual framework. Figure 1. 
The Health Belief Model as formulated by Rosenstock is a predictor of preventive 
health behavior. This model is based on values and expectations. It hypothesizes that 
people will generally not attempt to diagnose or prevent a condition unless they 
possess minimal levels of relevant health motivation and knowledge, perceive 
themselves as potentially vulnerable and the condition as threatening, are convinced 
of the efficacy of intervention, and see few difficulties in undertaking the i'--
recommended action. 
Predictors of participation m health promoting behaviors such as cancer t 
screening that have been documented in the literature include demographics and 
perceived benefits. Demographics include age, race and socioeconomic status. 
l 
Increasing age has been shown to be a predictor of decreased participation in cancer ~ I 
f screening. This observation is important in regards to prostate cancer, as it is known 
that the risk of developing prostate cancer increases with age. However Tingen et a! 
and Weinrich et a! have shown in their work that the opposite occurs with prostate 
. 
cancer. Tingen has documented that men age 60 - 70 years old are more likely to L 
participate in prostate cancer screening than men age 50- 59 years old.19•20,21 Race is 
also a predictor of participation as it has been shown that white men are more likely 
to participate in prostate cancer screenings. This low participation among African 
Americans is of concern since African Americans have the highest incidence of 
prostate cancer in the United States, have higher rates of metastatic disease, and have 
decreased survival rates.1,2,J 9•20 Similarly, a 1986 report by the American Cancer 
Society demonstrated that socioeconomic status is an important predictor of 
participation, with those earning more than $50,000 per year being more like to 
participate in prostate cancer screening.19•20,21 
Perceived benefits are described as beliefs about the effectiveness of the 
recommended action in reducing the health threat. 18 This variable has direct impact on 
whether or not one chooses to participate in screening. Important benefits that have been 
documented include "early detection", "early treatment", "know if I have cancer", "know 
that I am well", "so I can live longer", "stop cancer from growing", "learning the truth"?0 
Perceived benefits that are specific to African Americans include "prevention of illness" and 
"prevention of complications".22 Also important to consider are specific motivators of health 
seeking behavior. Weinrich eta! identified age, family history of prostate cancer, urinary 
symptoms and previous history of prostate cancer screening as motivators for participation in 
prostate cancer screening.21 For African Americans, Plowden eta! identified resource 
availability and the influence of significant others such as family and friends to be external 
motivators. Internal motivators were identified as perceived disability and death from a 
disease and unrelieved symptoms. Specifically health seeking behavior was linked to 
perceived outcome of a specific event, i.e. disability or death?2 Nivens et a! have also 
proposed that a relationship exists between overall exposure to prostate cancer information 
and prostate cancer screening. In this Cue to Participation in Prostate Cancer Screening 
Theory, Nivens suggests that men who recently have heard or read about prostate cancer 
screening are more likely to participate in screening.17 
Barriers to prostate cancer screening is defined as a conflict between two opposing 
factors that prevents a behavior from occurring.22 Barriers as described by Weinrich et al 
include embarrassment, sexual difficulty as complication of surgery, mistrust, cost, concern 
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about abnormal test results or cancer, lack of knowledge ofthe health care system, not 
having a regular doctor, inconvenient doctors hours, lack of cultural sensitivity programs, 
and fatalism.21 Plowden et al also described the following barriers, which are of particular 
importance among African Americans: lack of resources - money for special diets or 
facilities that provide primary prevention interventions, transportation, inconvenient office 
hours, limited knowledge of the health issues affecting African American men and 
community based resources available to respond to those health issues, and perceived lack of 
sensitivity and understanding by health care providers.22 Myers et al also described several 
barriers to follow-up of abnormal prostate cancer screening results. Theses barriers included 
concern about physical discomfort, time involved in going for further testing, worry that 
further testing would cause health problems or that further testing may find prostate cancer 
and concern that further testing would upset family members. 6 
These studies and many others have attempted to evaluate predictors for participation 
in prostate cancer screening, however, most of these studies have involved asking men of 
their intent to participate in screening. 19•20.21.22•23.24 Because a self-reported expression of 
intent to have a screening exam has not been correlated with actual behavior18, the study 
presented in this article will attempt to determine the predictors, motivators and barriers of 
participation in men who are actively participating in screening. Men who participated in a 
free prostate cancer screening program where given surveys to complete while at the 
screening site, demographic information was collected as well as information on the reasons 
the men chose to participate in a free screening program. 
Methods: 
This is the first part of a larger case- control study whose overall objective is to 
determine factors associated with regular participation of prostate cancer screening among 
high-risk men. The purpose of this work is to identifY facilitators and barriers to PSA and 
DRE prostate cancer screening among men in a southeastern city. Participants in the study 
come from a free prostate cancer screening database. The men volunteered for prostate 
cancer screening at an annual free screening program conducted at both a major academic 
health system and a community health center in one southeastern city during the time period 
from 1998-2001. Participants volunteered for screening on at least one occasion during the 
study period. Demographic data was collected from all screening participants at the time of 
screening and entered into a database. Data includes: date of birth, race, educational 
attainment, employment, acquaintance with someone who has prostate cancer, having a 
regular physician and PSA value. The participants were also asked to write in the most 
important reason they chose to participate in a free prostate cancer screening program. This 
researcher then organized these reasons into the following categories based on the 1997 pilot t 
study and facilitators described by Weinrich eta!: (A) I believe at my age I should get the 
digital rectal exam and PSA blood test done each year, (B) The free prostate cancer screening 
program is convenient, (C) I believe in protecting my health, (D) My doctor encouraged me 
to be screened, (E) If I had signs of prostate cancer I want to find out early so treatment 
decisions can be made early, (F) My wife, family member or someone else close to me 
encouraged me to be screened, (G) I believe that I am in control of what happens to my 
health, (H) Getting prostate cancer screening gives me peace of mind, and (I) Other. This 
information will be used to determine predictors and motivators for participation in free 
screenmg programs. Analysis of the questionnaires will focus on identifYing facilitators and 
barriers for men who are non-sustainers, and how they compare to sustainers. Sustainers are 
men who participated in the screening program two or more years. Non-sustainers are 
identified as men who participated in screening one year, but did not participate in 
subsequent years. For example, a non-sustainer is one who participated in the free screening 
program in 1998, but did not return for screening in 1999, 2000 or 2001. 
Data was entered and validated by this researcher and analyzed by SAS. 8.2. The 
analysis includes descriptive statistics and logistic regression. The purpose of the logistic 
regression model is to determine if participant demographics have a predictive effect on the 
primary outcome. The primary outcome examined in this study was sustained participation of 
an annual free prostate cancer screening for two or more years. The variables for the model 
are the baseline demographic variables of the participants collected at the time of initial 
presentation in the free screening program. There are eight variables entered in the model; 
age, race, education, employment, physician, family/friend (with prostate cancer), reason for 
participation, and PSA. All variables are categorical; physician and family/friend are 
dichotomized. Comparison is made of the characteristics of sustainers and non-sustainers in 
free prostate cancer screening programs. 
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Results: 
There were 1 024 participants in the free prostate cancer screening program between 
1998 and 2001. Table 1. Forty four percent (n=454) of participants self-identified as 
Black/African American and 51% (n=524) described themselves as White. Participants were 
generally between the ages of 50-59, 36% (n=333), at the time of their initial screening. 
Most participants of the program were well educated with 55% (n=513) having some college 
education or more. An additional19% (n=175) and 16% (n=152) graduated high school and 
attended technical school, respectively. Fifty nine percent (n=530) were employed and 36% 
(n=322) were retired. Mrican Americans were of approximately the same age and 
educational level as whites. Of those with a high school education, 49% were African 
American and 47% were White. Within the 50-59 age category, 51% were White and 45% 
were African American. The majority of participants had a regular physician, 68% (n=626) 
and most did not have someone close to them with prostate cancer, 58% (n=546). Ninety-
two percent (n=931) of participants had a normal PSA value (less than 4ng/ml) at the time of 
the initial screening. In summary the average participant was aged 50-59, employed, had 
some college or more of education and had a regular physician. 
Thirty-six percent (n=364) were identified as sustainers of the screening program. 
Table 2. Whites were more likely than Blacks to be sustainers, however this was not 
significant; OR=I.079 (CI 0.831- 1.401). Hispanics and Asians (referent group) were 
significantly less likely to be sustainers, OR 0.344 (CI 0.150- 0.790). In a comparison of all 
age groups, with those under the age of 40 used as the referent group, age was not found to 
significantly influence sustaining in the program. Those with a high school or technical 
school education were more likely to sustain than those with less than a high school 
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education, and those with some college education or more (referent group) were less likely to 
sustain than those with less than a high school education. These results, however, were not 
significant. Those with some college education or more were more likely to participate in the 
free screening program, however when compared to those with higher levels of education, all 
other educational groups were more likely to be sustainers; though only high school 
graduates were significantly different, OR 1.501 (CI 1.054- 2.138). 
In the under 40 age category participants were most likely to be Black. All of the 
Black participants in this age category had some college education or more. Participation 
among Blacks decreased with age, whereas participation increased with age among Whites. 
Graph 1. Retirees and the disabled were more likely than employed people to be sustainers, 
but this was not significant. Having a regular physician or having a close acquaintance with 
prostate cancer does not significantly impact whether one will have sustained participation in 
a free prostate cancer screening program. A PSA value between 4ng/ml and 10 ng/ml was 
shown to significantly influence sustaining in the free screening program; OR 0.526 (CI 
0.291 - 0.949). A logistic regression model was done as an exploratory analysis. This was 
done to determine if any of the baseline demographic variables had an effect on sustaining in 
the free screening program for this dataset. After controlling for race and education among 
the educational categories, graduating from high school continued to significantly influence 
sustaining in the program; p < 0.020. At an oc = 0.05 significance level, controlling for all 
variables, only education was found to have an a significant effect on sustaining; p<0.0317. 
The most important reasons reported for participation in the free prostate cancer screening 
program were convenience and cost. Table 3. 
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Discussion: 
Consistent with the literature, this study found that whites, 50-59 years old, and with 
higher levels of education are active participants of prostate cancer screening. However, the 
literature to date has suggested that African Americans, 50-59, were least likely to participate 
in screening. This study, to the contrary, demonstrated a participation rate of 44% among 
Blacks compared to 51% for whites. Blacks were of approximately the same age and 
educational level as whites. It is difficult to pinpoint what may have attributed to the 
excellent rate of participation among blacks, but advertisement of the screening program may 
well have played a contributory role. Advertisement for this free screening was broad based 
and involved newspaper, radio, mailed postcards and neighborhood flyers. Other studies have 
shown that whites are most likely to hear of screening programs through newspapers and 
blacks through the radio. Many participants in our study also reported they received a 
postcard in the mail. Further research needs to be done to assess whether personalized 
recruitment (i.e. postcard in the mail) rather than mass recruitment is a motivator for 
participation among blacks. 
The most interesting finding of this study was that participation decreases with age 
among blacks, but increases with age among whites. Prior research reports that increasing 
age is a predictor for decreased participation in cancer screening. However, Tingen et a1 
revealed that among 60-70 year olds there was in an increase in participation as compared to 
50-59 year olds.19 Additionally, previous studies in this region have shown no significant 
difference in perception of risk for prostate cancer between blacks and whites, with both 
groups reporting their risk as the "same as the average man", and similarly black men 
reported that they perceived the benefit of going for screening at a level similar to that of 
white men.25• 26 However, other studies have shown that blacks were significantly less likely 
to be knowledgeable of prostate cancer risk factors, including race and family history .26•27 
Although no significant difference was found between education level and race, or education 
and age, we did not assess the prostate cancer risk factor knowledge among participants. We 
did note however that younger African American participants were more highly educated, 
specifically all of the African American men in the under 40 age group had graduate or 
professional education. We hypothesize that the younger black participants have an 
increased knowledge base of prostate cancer risk factors and perhaps represents a new cohort 
of African American participants. This group of men could also represent the phenomenon 
seen in many primary care settings of the "worried well". These are individuals who are in 
good health and are at low risk for certain disease entities, yet insist upon being screened or 
tested for these diseases. It will be of interest to see whether this trend of increased 
participation continues over time as this group of men ages to the appropriate screening age. 
This study also found that education was significant predictor for sustained 
participation in the free screening program. Education often serves a proxy for certain 
factors related to health behaviors. In this case education may serve as a proxy for literacy 
and one's ability to understand the controversies surrounding prostate cancer screening such 
that one is able to make an informed decision. Or it may serve as a proxy for skill level and 
suggest employability and therefore indicate whether one is able to have health insurance and 
access to care. Additional research on predictors of health behaviors, especially among men, 
will help to determine which is at play when we say education has a significant effect on 
sustaining and how does one determine which is most influential. 
Based on education levels, employment status and number of participants reporting 
they have a regular physician, one would expect that the majority of these men have health 
insurance and therefore access to primary (preventive) health care services, yet the most 
common reason for participation in the prostate cancer screening program was because it was 
free. In prior research, the major barrier to participation in prostate cancer screening was 
cost.19 In another study of knowledge, attitude and beliefs about prostate cancer screening in 
African Americans, the authors found 88% if the subjects believed it would be best to 
participate in prostate cancer screening, with 80% agreeing to have annual screening 
provided it was free.23 One hypothesis is that "free" carries additional value besides 
monetary. More work will have to be done to assess what connotation "free" carries in 
regards to the importance of health care services, but perhaps because health care services 
traditionally carry a cost, when it is offered to the public as free it implies some increased 
level of magnitude or consequence. In other words these men may think "health professionals 
must believe this disease is so significant that they offer a free screening to make sure I have 
access to it". 
Also important to get more understanding of is the reason that these highly educated 
men who seemingly have access to the health care system would choose to participate in 
mass prostate cancer screening, including both a DRE and PSA, rather than having these tests 
done in the privacy of their physician's office. While little is known about the motivators for 
men in regards to participation in cancer screening, the participants in this study listed 
convenience high among their reason for participation. The men reported that they preferred 
not having to take off from work or make an appointment. There is conflicting data in the 
literature about the popularity of mass screenings; one study showed mass screening was 
most popu1ar among whites, whereas private appointment in a prostate cancer-screening 
program was the preferred method for blacks. To some extent there is also a certain degree 
of anonymity when one participates in a mass screening program, conceivably this as well 
may be a motivating factor for men. 
Limitations of this study include that is the study was conducted in one single 
geographic location. It may be difficu1t to generalize the resu1ts of this study to other areas in 
the United States. Similarly, the study involves a self-selected popu1ation of men who chose 
to attend prostate cancer screening events. Our resu1ts are encouraging however, because this 
region is known to have one of the highest prostate cancer rates in the nation and the fact that 
we had such a high participation rate among African Americans suggests that these men are 
becoming more knowledgeable about their risk factors. Also the fact that demographics were 
not predictors of sustained participation suggests that participation cannot be attributed to 
race or socioeconomic status alone. Helpful information will gathered in the remainder of 
this study that addresses barriers to participation among those who did not sustain in the 
program. Another limitation is that information obtained was by self-report and thus there is 
not way to validate the accuracy of the information collected. And finally, participants came 
to this event because it was free and convenient. As of now there is no information collected 
on how the men are following up if they have an abnormal result. If cost is a primary 
motivator of participation it is prudent that follow up care is also free and convenient. 
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Table 1. 
Characteristics White 
A"e 
>80 66.67% 
70-79 73.05% 
60-69 57.08% 
50-59 51.35% 
40-49 61.71% 
<40 85.71% 
Education 
<High School 36.71% 
High School Graduate 47.93% 
Techoical School 40.41% 
Some college or more 59.63% 
Employment 
Retired 59.87% 
Disabled 38.46% 
Unemployed 54.17% 
Employed 48.34% 
Phvsician 
Yes 55.72% 
No 44.13% 
Family/Friend 
Yes 53.91% 
No 50.19% 
African American 
33.33% 
25.53% 
38.05% 
45.05% 
33.71% 
7.14% 
56.96% 
49.11% 
56.85% 
36.51% 
37.83% 
61.54% 
33.33% 
47.36% 
41.63% 
49.82% 
43.94% 
45.25% 
Other 
0% 
1.42% 
4.87% 
3.6% 
4.57% 
7.14% 
6.33% 
2.96% 
2.73% 
3.86% 
2.3% 
0% 
12.5% 
4.31% 
2.65% 
6.05% 
2.16% 
4.56% 
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Table 2. 
Sustainers Non Sustainers OR(95 %CI) A-~ 
N*~364 N*~660 (95% 
A2e n*-358 n*-574 
>80 3.63% 2.44% 2.32 (0.76 -7.08) 1.68 (0.43 6.64) 
70-79 15.64% 14.81% 1.65 (0.68- 3.99) 1.30 (0.44- 3.83) 
60-69 29.05% 21.43% 2.11 (0.89- 4.99) 1.38 (0.51-3.75) 
50-59 32.68% 37.63% 1.35 (0.58- 3.17) 0.96 (0.37- 2.50) 
40-49 16.76% 20.21 % 1.29(0.53-3.11) 0.91 (0.34- 2.44) 
<40 2.23% 3.48% 
Race n~357 n-573 
White 53.50% 50.79% 2.65 (1.12- 6.13) 2.98 (0.98- 8.94)* 
Black 44.54% 44.33% 2.50 (1.06- 5.87) 2.85 (0.95- 8.59)* 
Other 1.96% 4.89% 
Education n-323 n-566 
<High School 9.60% 8.48% 1.32 (0.81- 2.16) 1.08 (0.59- 1.96) 
High School Graduate 21.98% 17.31% 1.49 (1.04 -2.13) 1.75 (1.17 -2.64)* 
Technical School 18.27% 15.55% 1.37 (0.94- 2.01) 1.62 (1.05- 2.50) 
Some college or more 50.15% 58.66% 
Employment n-317 n-587 
Retired 39.12% 33.73% 1.24 (0.92 -1.65) 1.03 (0.67- 1.59) 
Disabled 3.15% 2.73% 1.24 (0.55 -2.78) 0.86 (0.35- 2.13) 
Unemployed 1.58% 3.58% 0.47 (0.18- 1.27) 0.58 (0.18- 1.82) 
Employed 56.15% 59.97% 
Physician n-327 n-595 
Yes 71.56% 65.88% 1.30 (0.97 -1.75) 1.16 (0.82 -1.64) 
No 28.44% 34.12% 
Family/Friend 
Yes 45.37% 39.50% 1.27 (0.97- 1.67) 1.30 (0.96- 1.78)* 
No 54.63% 60.50% 
PSA n-356 n-660 
>10 1.97% 1.82% 1.04 (0.41-2.67) 0.562 (0.16- 1.95) 
4-10 4.21% 7.73% 0.53 (0.29 - 0.95) 0.340 (0.16- 0.71) 
<4 93.82% 90.45% 
.. N differs from n at each vanable because not all participants responded to that questiOn 
t Each factor is adjusted for all other factors: age, race, education, employment, physician, family/friend, reason 
and PSA 
* p< 0.1 
Table 3. 
Other Important Reasons for Participation in the Free Prostate Cancer 
Screening Program 
Reason for participation 
Free/Insurance/Financial 
Participated in this screening program in the past 
Heard about program/Received flyer in the mail 
Time for a "check up" 
Cancer center reputation 
Second opinion/additional check 
No regular doctor 
Urological Symptoms 
Family history/Know someone with prostate cancer 
Regular Doctor does not recommend screening 
To learn more information about prostate cancer 
Regular doctor unavailable/schedule conflict 
PSA test (blood work) 
Never screened before 
Doctors here are more knowledgable than personal doctor 
Volunteer in screening program 
Previous diagnosis of prostate disease 
Did not know which urologist to go to 
PSA results confusing 
Less embarrassing 
Free screening program will be more truthful 
Community committed to the health of its citizens 
More comfortable 
Hesitant to see regular doctor 
Enjoy fellowship with friends 
No Urologist 
AARP 
Support the Cause 
Frequency 
368 
115 
66 
53 
53 
48 
31 
20 
16 
15 
12 
12 
9 
7 
3 
2 
2 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
These reasons were written in by participants at the time of screening- includes reasons from all visits not just 
baseline. 
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I 
Graph I. 
Age Distribution of Participants in Free Prostate Screening Program by Race 
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